Efficacy Study of Auriclosene Irrigation Solution on Urinary Catheter Patency

PHASE2UnknownINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

January 31, 2016

Conditions
Urinary Catheter Blockage and Encrustation
Interventions
DRUG

Auriclosene Irrigation Solution, 0.2%

DRUG

Auriclosene Vehicle Solution

Trial Locations (17)

12208

The Urological Institute of Northeastern NY, Albany

21117

Chesapeake Urology Research Associates, Owings Mills

23249

McGuire Veterans Affairs Medical Center, Richmond

27262

Peters Medical Research, High Point

27834

Eastern Urological Associates, Greenville

28207

McKay Urology, Charlotte

44060

Great Lakes Medical Research, Mentor

53226

Medical College of Wisconsin, Milwaukee

53715

Dean Clinic, Madison

87109

Urology Group of New Mexico, Albuquerque

90027

Southern California Permanente Medical Group, Los Angeles

90242

Los Amigos Research and Education Institute, Downey

90822

VA Long Beach Healthcare System, Long Beach

01805

Lahey Hospital and Medical Clinic, Burlington

07631

Urology Center Research Institute, Englewood

08043

Delaware Valley Urology, LLC, Voorhees Township

07052

Kessler Institute for Rehabilitation, West Orange

Sponsors
All Listed Sponsors
lead

NovaBay Pharmaceuticals, Inc.

INDUSTRY

NCT02130518 - Efficacy Study of Auriclosene Irrigation Solution on Urinary Catheter Patency | Biotech Hunter | Biotech Hunter